基于昆的化合物可以抑制作用于DNA的各种酶
bioRxiv : the preprint server for biology
|April 15, 2024
概括
新的林基化合物抑制DNA甲基转移酶,为疾病提供潜在的治疗方法. 这些非核酸抑制剂通过激活DNA损伤反应,在癌症治疗中表现有前途.
科学领域:
- 表观遗传学和分子生物学
- 药物化学和药物发现
背景情况:
- 基因甲基化是调节基因表达的关键表观遗传机制,异常甲基化与癌症等疾病有关.
- 目前的低甲基化剂因毒性而面临局限性,需要开发新的非核酸抑制剂.
研究的目的:
- 鉴定基因林基类型作为DNA甲基转移酶的潜在非核酸抑制剂.
- 探索它们的作用机制和潜在的治疗应用.
主要方法:
- 合成和表征15种基于类素的类似物.
- 在体外抑制对人类DNMT1和细菌甲基转移酶 (CamA,CcrM) 的测定.
- 在癌细胞中进行的DNA-蛋白相互作用研究 (间隔) 和细胞检测.
主要成果:
- 化合物9和11显示出对人类DNMT1和细菌CAMA的低微分子抑制功效.
- 化合物9和11入CAMA结合的DNA中,诱导形状变化.
- 在癌细胞中通过化合物11抑制其他DNA作用酶 (聚合酶,糖酶) 和p53激活.
结论:
- 基于氨酸的类似物代表了一个有前途的非核酸DNA甲基转移酶抑制剂类别.
- 化合物11通过癌细胞中的p53激活触发了DNA损伤反应,表明了治疗潜力.
- 这项研究扩大了针对表观遗传点的DNA插曲抑制剂的范围.
更多相关视频
05:32Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping
Published on: May 12, 2023
1.3K
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
13.8K
相关概念视频
Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Restriction Enzymes
30.7K
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
30.7K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
556
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
556
